Seres Therapeutics Stock (NASDAQ: MCRB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 57.45K / 3.79M |
Day Range | - - - |
52 Wk Range | 0.54 - 2.78 |
Market Cap | $173.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 14.6% |
Days to Cover | 10.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Seres Therapeutics (NASDAQ:MCRB) through any online brokerage.
Other companies in Seres Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
Seres Therapeutics has a consensus price target of $9.36.
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $1.14 last updated September 23, 2024 at 9:23 AM EDT.
There are no upcoming dividends for Seres Therapeutics.
Seres Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Seres Therapeutics.
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.